• No results found

Efficacy and safety of biological and targeted synthetic DMARDs: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis

N/A
N/A
Protected

Academic year: 2020

Share "Efficacy and safety of biological and targeted synthetic DMARDs: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis"

Copied!
12
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Table 1Effect of TNFi on ASAS20, ASAS40 and BASFI in patients with r-axSpA (mNY) (RCTs)
Table 2Effect of TNFi on ASAS20, ASAS40 and BASFI in patients with nr-axSpA (ASAS criteria) (RCTs)
Table 4Safety outcomes for TNFi on observational studies
Table 5Effect of new biological and targeted-synthetic DMARDs on ASAS20 and ASAS40 responses in patients with axSpA
+2

References

Related documents